System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Viral Shah is an expert in Endocrinology at Indiana University School of Medicine (United States). As of October 2026, ScienceLeadR ranks Viral Shah in the top 1% of experts worldwide for Diabetes Mellitus and Glucose Metabolism Disorders. Viral Shah has authored 70 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 3 of them ongoing. SLR score: 433 (community average: 125). How the SLR is computed.

LeadR Profile

Viral Shah Indiana University School of Medicine United States
433 ScienceLeadR Reputation 433

Unlock

Register Login
Network Map

Endocrinology

Subspecialties: Public Health - Gastroenterology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2013 - 2026
Source: PubMed

Indiana University School of Medicine

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 70

Citations

Citations: 70 1st author: 10 Last author: 18 Unique author: 4

Main journals

J Diabetes Sci Technol 9
Clinical Diabetology 5
Diabetes Technol Ther 4
Diabetes Care 3
Diabetes Obes Metab 3

Best Journals

Lancet Diabetes Endocrinol 1
N Engl J Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The Case for Evaluating Continuous Glucose Monitoring as a Diagnostic Tool for Diabetes.
PMID 42847278 — diabetes mellitus, research design, continuous glucose monitoring		J Diabetes Sci Technol20260
Diabetes Technology in the Primary Care Setting: An American Diabetes Association Scientific Statement.
PMID 42803468 — diabetes mellitus, workflow, continuous glucose monitoring		J Diabetes Sci Technol20260
Glycaemic Changes After Semaglutide Discontinuation in Adults With Type 1 Diabetes Using Automated Insulin Delivery: Analysis of the ADJUST-T1D Extension Study.
PMID 42675550 — diabetes mellitus, insulin, obesity, therapeutics, diabetes mellitus, type 1, continuous glucose monitoring, semaglutide		Diabetes Obes Metab20260
Impact of Pharmacy Benefit Manager Organizations on Diabetes Management.
PMID 42661143 — diabetes mellitus, pharmacy, medication adherence, therapeutics		J Diabetes Sci Technol20260
Type 1 Diabetes Management Beyond Insulin: Aligning Evidence, Research, and Regulation.
PMID 42527007 — diabetes mellitus, insulin, research, diabetes mellitus, type 1		Endocrinol Metab Clin North Am20260

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 6

By phase:

N/A 3
Phase 2 1
Phase 3 1
Phase 4 1

By status:

Completed 3
Recruiting 3

By type:

Interventional 5
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 1
multicentric5to9 0
multicentricup10 3

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Efficacy of the Omnipod 6 System Compared With the Omnipod 5 System
NCT07579702 — diabetes mellitus, insulin, insemination, artificial, heterologous, diabetes mellitus, type 1, diabetes mellitus, type 2		N/ARecruiting2026
Evaluation of the Fully Closed Loop Omnipod System in Type 2 Diabetes
NCT07521475 — diabetes mellitus, safety, insulin, insemination, artificial, heterologous, therapeutics, diabetes mellitus, type 2		N/ARecruiting2026
Bionic Pancreas in CFRD
NCT06449677 — diabetes mellitus, injections, insulin, fibrosis, algorithms, pancreas, cystic fibrosis, bionics, infusion pumps, therapeutics, continuous glucose monitoring		Phase 3Recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS